Chardan 2nd Annual Genetic Medicines Conference, NYC (US)

15th Gilbert Dupont Healthcare Conference, Paris, France

GenSight Biologics reports €49 million cash position as of March 31, 2018 and provides update on GS010

21st Annual Meeting ASGCT, Chicago (IL), US

GenSight Biologics Reports Full Year 2017 Financial Results

GenSight Biologics reports €55 million 2017 year-end cash position and provides corporate update

GenSight Biologics Appoints Julio Benedicto as Vice President of Marketing

GenSight Biologics to Participate in Multiple Conferences in November

GenSight Biologics Reports its Cash Position as of September 30, 2017

GenSight Biologics Appoints Barrett Katz as Chief Medical Officer